Tag: Romosozumab

Approximately one in two women in the United States will suffer a fracture in their lifetime due to osteoporosis, a chronic and debilitating disease. Many people are searching for a new and convenient treatment, with the query 'What is the new pill for osteoporosis?' being common. However, recent advancements have focused on injectable therapies and biosimilars, while novel oral medications remain in the research and development pipeline.

According to the European Medicines Agency, Evenity is indicated for severe osteoporosis in postmenopausal women with a high risk of fractures. The medication, which is delivered via a prefilled syringe, helps build new bone tissue to strengthen the skeleton and reduce the incidence of future fractures.

Worldwide, 1 in 3 women over age 50 will experience a fragility fracture due to osteoporosis [1.5.2]. As patients and doctors ask, 'What is the new drug for osteoporosis 2025?', the landscape is shifting towards advanced biologics and a wave of cost-saving biosimilars.